Improving HIV self-care for people who inject drugs

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot randomized controlled trial aims to assess the feasibility and acceptability of an intervention designed to enhance HIV self-care among HIV-positive individuals who inject drugs and are not optimally engaged in HIV care. Participants will be randomly assigned to receive either a mobile application-facilitated directly observed therapy (iDOT) alone or iDOT combined with the iSTRIVE intervention, which includes therapy sessions focused on emotion regulation and communication skills. The study will take place at Fenway Health in Boston, MA, and participants will be compensated for their involvement and adherence to the protocol.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* HIV positive
* HIV virally unsuppressed (\>20 copies/mL) in past year or no past-year HIV viral load result
* Drug use behavior endorsed in past 6 months
* Able to provide informed consent
* 18 years or older
* English speaking

Exclusion Criteria:

* HIV negative
* Denying drug use in past 6 months

Where it's running

• Fenway Community Health
  Boston, Massachusetts, United States Recruiting

Study contacts

• Study coordinator: Abigail W Batchelder, PhD, MPH
• Email: abigail.batchelder@bmc.org
• Phone: 6172670900

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Collaborative care program for young Black and Latino men at risk for HIV

  This study tests a new support program to help young Black and Latino men at risk for HIV start taking prevention medication and manage their substance use better.

  Recruiting Children's Hospital of Philadelphia · Baltimore, Maryland and 1 other locations · NCT06585631

• HEAT telemedicine program for HIV and addiction care

  This project will try a telemedicine program to deliver addiction treatment to adults living with HIV in Alabama who report opioid or stimulant misuse.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT06370481

• Helping MSM with HIV and substance use disorders overcome stigma and shame

  This study is testing a new program to help men who have sex with men and gender minorities living with HIV and substance use issues feel better about themselves and manage their health by reducing stigma and shame.

  Recruiting at 2 sites Boston University · Miami, Florida and 1 other locations · NCT05934305

• Project SHIELD 2.0: Police Education to Support Public Health in Kentucky

  Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Lexington, Kentucky · NCT07804121

• New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV

  This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.

  Recruiting Indiana University · Lilongwe · NCT07793006

• Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV

  This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.

  Recruiting Fenway Community Health · Boston, Massachusetts · NCT07762066

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.